Meg Knowling
Impact in
- Cancer Research top 2%
- Breast Cancer Treatment Studies
-
- Breast Lesions and Carcinomas
Papers in
-
- Histone Deacetylase Inhibitors Research 2
- PI3K/AKT/mTOR signaling in cancer 2
-
- Sarcoma Diagnosis and Treatment 4
- Co-authors
- Joseph Ragaz (1 shared paper)Karen Gelmon (1 shared paper)C Coppin (1 shared paper)R. E. Durand (1 shared paper)Kenneth S. Wilson (1 shared paper)Ivo A. Olivotto (1 shared paper)L. Weir (1 shared paper)Natasha Phillips (1 shared paper)
- Journals
- Annals of Oncology (4 papers)JNCI Journal of the National Cancer Institute (2 papers)Journal of Clinical Oncology (2 papers)The Oncologist (1 paper)Breast Cancer Research and Treatment (1 paper)
- Partner nations
- CanadaUnited StatesNew Zealand
In The Last Decade
Meg Knowling
14 papers receiving 1.0k citations
Meg Knowling's Hit Papers
Peers
Comparison fields: 5 of 62
- Cancer Research 579
- Pathology and Forensic Medicine 217
- Radiation 88
- Oncology 227
- Pulmonary and Respiratory Medicine 174
Countries citing papers authored by Meg Knowling
This map shows the geographic impact of Meg Knowling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meg Knowling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meg Knowling more than expected).
Fields of papers citing papers by Meg Knowling
This network shows the impact of papers produced by Meg Knowling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meg Knowling. The network helps show where Meg Knowling may publish in the future.
Co-authors
The 25 scholars most cited alongside Meg Knowling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Locoregional Radiation Therapy in Patients With High-Risk Breast Cancer Receiving Adjuvant Chemotherapy: 20-Year Results of the British Columbia Randomized Trial Hit paper breakdown → | 2005 | 803 |
| 2 | 2006 | 74 | |
| 3 | 2015 | 43 | |
| 4 | 1995 | 36 | |
| 5 | 1989 | 32 | |
| 6 | 2009 | 30 | |
| 7 | 2014 | 18 | |
| 8 | 2008 | 12 | |
| 9 | 2005 | 7 | |
| 10 | Phase II study of mitoxantrone in untreated and previously minimally treated patients with metastatic soft tissue sarcomas. | 1987 | 7 |
| 11 | 2007 | 5 | |
| 12 | Perioperative chemotherapy for primary sarcoma of bone. | 1989 | 4 |
| 13 | 2001 | 3 | |
| 14 | 1992 | 2 |
About Meg Knowling
Meg Knowling is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Otorhinolaryngology, having authored 14 papers that have together received 1.1k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (4 papers), Head and Neck Cancer Studies (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Breast Cancer Treatment Studies (2 papers), Gastrointestinal Tumor Research and Treatment (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Cancer Mechanisms and Therapy (1 paper) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Cancer Research (579 citations), Pathology and Forensic Medicine (217 citations), Radiation (88 citations), Oncology (227 citations) and Pulmonary and Respiratory Medicine (174 citations). Meg Knowling has collaborated with scholars based in Canada, United States and New Zealand. Frequent co-authors include Joseph Ragaz, Karen Gelmon, C Coppin, R. E. Durand, Kenneth S. Wilson, Ivo A. Olivotto, L. Weir, Natasha Phillips, John J. Spinelli and Mohamed Manji. Their work appears in journals such as Annals of Oncology, JNCI Journal of the National Cancer Institute, Journal of Clinical Oncology, The Oncologist and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.